Therachon (Pfizer)

Description: 

Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases that currently have no available treatments. The company’s lead pipeline candidate, TA-46, is a novel protein therapy in development for achondroplasia, the most common form of short-limbed dwarfism. 

Location(s): 
Therachon AG
Basel
Switzerland
Therachon SAS
Nice cedex 2
France